JPMorgan upgrades biopharma stock to overweight on strong drug pipeline
- Posted on October 8, 2025
- By CNBC
- 2 Views
JPMorgan upgrades biopharma stock to overweight on strong drug pipeline
JPMorgan foresees shares of Ionis Pharmaceuticals rising another 16% from their Tuesday close after a 170% runup in six months.
